Finding the Right Dosage for the Esketamine Nasal Spray for Depression
When the FDA approved the fast-acting esketamine nasal spray Spravato™ in early 2019, it gave newfound hope to many people who struggle with treatment-resistant depression (TRD), or any major depressive